Potpourri
I wasn't sleeping Mike, really!
All things PAA
Tooling Around
100
In this visual depiction of the PAA Path to Adoption, what does the question mark (beginning) represent ?
Indicated Patients
100
What are the three categories of barriers shown here with an "x"?
Readiness, Structural, and Behavioral Barriers
100
What does the blue bubble represent ?
Medtronic Market Share
100
I know the AF prevalence in the US and I need to find out the same for Germany. THIS tool will help me find it.
Prevalence Calculator uses an epidemiologic formula to calculate a prevalence in another country.
200
Name this popular Indian snack food.
Samosa
200
What are the two groups of factors that make up SOC Foundation score ?
1) Therapy Readiness and
2) Structural Barriers
200
When newly indicated patients, diagnosed or not, are added to the prevalence pool every year, THIS metric changes.
Incidence pool
200
In the following portfolio bubble chart, which opportunity represents the most compelling market development opportunity?
Heart Failure (largest bubble, smallest industry penetration)
300
What two types of evidence drive adoption of a therapy?
1. Clinical Evidence
2. Economic Evidence
300
The formula for Potential at SOC is below. What is the missing element ?
15% of untreated prevalence
300
In this formula for prevalence, what does the variable A represent?
Lifespan with Condition
Prev = I x LSWC
300
In which part of the Opportunity Assessment can I enter the following information :
The Market and Barrier Projection section
Also accepted: therapy readiness barriers
400
Name the year this song was released
1980
400
Who is PITR and why is he important?
PITR= patient in the red shirt, the indicated patient that benefits most from your therapy and technology.
He is important to understand where to focus your market development efforts and your efforts are to increase access to your therapy or technology for patients like him.
400
What is the annual adoption rate (AAR) and how is it calculated?
AAR is an indicator of speed of penetration and is measured as:
Therapy Penetration / Years in the Market
400
In the Rogers' Adoption Curve for Argentina's Cardiovascular therapies, which therapies have clearly crossed the chasm?
TAVI (42% penetration) and
catheter ablation (30%)
500
If I had to invest in resolving structural barriers, what would be two logical barriers to address?
Associated Products and User Adaptation
500
Visually communicating an opportunity typically consists of 1) opportunity size and what two other elements (#2 and #3 below)?
Therapy Attractiveness (Y)
Market Development Phase (X)
500
In what case would an incidence figure equal prevalence?
When Life Span With Condition (LSWC) equals 1
example :Kyphoplasty for VCF
500
This PAA tool allows one to create and plan new contexts for market development.
The PAA Scenario Planner 